Latest news with #aging population
CNA
18-07-2025
- General
- CNA
Are more elderly Singaporeans living alone a concern?
Scroll up for the next video X Are more elderly Singaporeans living alone a concern?
Yahoo
16-07-2025
- Health
- Yahoo
Japan Smart Home Healthcare Market to Worth Over US$ 9622.53 Million By 2033
Japan's smart home healthcare market is rapidly evolving, driven by an aging population, government support, and technological innovation, creating significant opportunities for advanced home-based care, remote monitoring, and digital health solutions. Chicago, July 16, 2025 (GLOBE NEWSWIRE) -- The Japan smart home healthcare market was valued at US$ 1,185.10 million in 2024 and is expected to reach US$ 9,622.53 million by 2033, growing at a CAGR of 26.20% during the forecast period 2025–2033. The Japan smart home healthcare market is expanding precisely because two irresistible forces—accelerated population aging and world-class engineering prowess—are converging. By 2025, nearly nine million Japanese residences will qualify as 'smart homes,' thereby creating a vast launchpad for sensor-rich, service-oriented medical solutions. Moreover, a demographic tidal wave is cresting: eight million baby boomers will celebrate their 75th birthdays that same year, thrusting long-term care into the national spotlight. Government projections also point toward 6.87 million households headed by someone aged 65 or older and 3.635 million led by citizens 75-plus by 2040, reinforcing how essential the Japan market will become to daily living. Consequently, the sector has blossomed into a ¥1.2 trillion ($8.6 billion) public-sector priority, and—because money follows need—private investors are racing to participate. Explore a Complimentary Report Sample: What truly sets Japan apart, however, is its determination to deliver connected care 'within the tatami mat,' thus preserving independence while easing pressure on busy clinics. Therefore, the conversation now extends far beyond consumer electronics and encompasses AI diagnostics, robotic rehabilitation, digital therapeutics, retrofittable assistive hardware, and data platforms that weave everything together. This press release explores eight interlocking dimensions—start-ups, investments, products, disease drivers, regulation, key players, core technologies, and consumer trends—showcasing 100 individual statistics that collectively illustrate why Japan has become the world's premier testbed for smart-home-enabled healthy ageing. Key Findings in Japan Smart Home Healthcare Market Market Forecast (2033) US$ 9,622.53 Million CAGR 26.20% By Technology Wireless (92.0%) By Product Testing, Screening, and Monitoring Products (77.0%) By Services Skilled Nursing Services (28.70%) By Application Health Status Monitoring (68.90%) By Indication Cardiovascular Disorder & Hypertension (24.5%) Top Drivers Japan's extreme aging demographics driving unprecedented smart healthcare innovation demand Government policies promoting robotic eldercare solutions for national healthcare sustainability Japanese consumers' high technology acceptance accelerating smart home healthcare adoption Top Trends Smart home market expanding from 5.67 to 9.00 billion by 2029 Robotic caregiving systems increasingly integrated into Japanese residential healthcare facilities Digital therapeutics becoming prominent feature in Japan's home healthcare ecosystem Top Challenges High implementation costs limiting smart healthcare adoption in residential settings Cultural preferences for human caregivers over automated healthcare technology solutions Interoperability barriers between diverse smart home healthcare devices and platforms Agile Start-Ups Spark Continuous Innovation Within Seniors-Focused Connected Home Care Ecosystem Expansion Grass-roots ingenuity fuels much of the momentum inside the Japan smart home healthcare market, and, as a result, 42 smart-home start-ups are currently active. Importantly, 15 of those have secured external funding, while eight have already advanced into Series A-plus territory. Because entrepreneurship never rests, an average of two new smart-home companies has launched every year for the past decade. Widening the lens to include general health-AI ventures pushes the domestic company count to 115, showing how rapidly cross-pollination occurs. For example, CrossLog links clinicians and home-based patients; Atonarp builds real-time molecular-profiling tools; and Anshin Support Co., Ltd. offers always-on lifestyle monitoring—recently attracting capital from trading-house giant Sojitz. Meanwhile, design-driven mui Lab (est. 2014) sells wood-grained control hubs, and its contemporary Nature Global lets seniors command air-conditioners remotely—an essential convenience during sticky Japanese summers. Likewise, security specialists Photosynth and Bitkey retrofit doors for caregiver access, whereas med-wearable innovator Syrinx restores lost voices through a hands-free electrolarynx. Diagnostic creativity is also thriving: Tokyo-based CREWT Medical Systems' portable 'IMOvifa' detects glaucoma on the go, and AI Medical Service targets early gastrointestinal-cancer detection. Finally, digital-therapeutic developer CureApp, elder-care AI champion ExaWizards, chronic-back-pain analyst Aillis, cell-analysis visionary ThinkCyte (est. 2016) and newcomer Boston Medical Sciences (est. 2023) further underline the sector's depth. Capital Inflows Accelerate Research And Scale Across Evolving Digital Health Landscape Nationwide Because innovation needs fuel, investor confidence has risen sharply in the Japan smart home healthcare market. For example, in 2024 MEDIROM Healthcare Technologies welcomed M3, Inc. into a Series A for MEDIROM MOTHER Labs at a pre-money valuation of ¥9 billion. Simultaneously, cloud heavyweight Naver Cloud earmarked US $400 million for AI infrastructure aimed at elder care, perfectly aligning with the government's ¥1.2 trillion 'Digital Transformation in Elderly Care' roadmap that targets 2030. In addition, a dedicated 10-year fund launching in 2025 will bankroll drug-discovery start-ups, thus broadening the innovation funnel. Measuring the market's heft is straightforward: Japan's digital-health revenues stood at US $6.15 billion in 2024, while the broader smart-home space hit US $7.61 billion, telemedicine US $5.2 billion, and telehealth US $1.4 billion. Regionally, the country's US $2 billion commitment to AI-driven elder care adds momentum to an Asia-Pacific surge. Zooming back to individual raises, mui Lab has attracted US $1.84 million; TechMagic, US $16.8 million; and PacPort has just closed its Series A. Meanwhile, ThinkCyte has amassed US $83.2 million, Aillis US $36.3 million, and fresh-faced Boston Medical Sciences US $8.79 million. Put together, these figures highlight a financing pipeline robust enough to shepherd prototypes all the way to large-scale domestic—and ultimately global—deployment inside the Japan smart home healthcare market. Cutting-Edge Devices Elevate Safety Comfort And Clinical Outcomes In Elderly Households Countrywide For continuous peace of mind, Anshin Support provides 24/7 home monitoring services for the elderly. Tokyo's Future Care Lab is developing a Shower Bating Device specifically for nursing care. The same lab is also working on a Rise Assisting Robot designed to help caregivers with the physical task of transferring individuals. Syrinx's wearable, hands-free electrolarynx is a life-changing device that helps restore a user's voice. PARO, a therapeutic robot seal, is widely used to provide cognitive stimulation for individuals with Alzheimer's and dementia. Naver Cloud's Clova Care Call is an AI-powered platform that automates daily check-ins and medication reminders for seniors. A collaboration between NEC Corporation and Tokyo Medical and Dental University has resulted in a technology that supports self-care for chronic lower back pain. The JWG-1 is a new device that can retrofit manual wheelchairs, converting them into electric-powered models. Chronic Diseases Underscore Need For Preventive Home-Based Monitoring And Rehabilitation Innovations Today Demand for connected solutions is rooted in hard epidemiology in the smart home healthcare market. In 2021 stroke alone imposed 2,016.2 DALYs per 100,000 citizens, closely followed by Alzheimer's and other dementias at 1,988.5. Next came low-back pain (1,748.4 DALYs), ischemic heart disease (1,412.0), and lung cancer (1,166.3). Mortality data tell the same story: Alzheimer's led with 135.3 deaths per 100,000, stroke followed at 114.9, ischemic heart disease at 96.5, lung cancer at 72.1, and lower respiratory infections rounded out the top causes. Among seniors, hypertension is the most prevalent chronic disease, and diabetes continues its upward march. Historically, cancer, heart disease, and cerebrovascular conditions have dominated Japanese mortality since the 1950s, embedding a culture keenly aware of prevention. Consequently, continuous monitoring, early-warning analytics, and rehabilitation robots are viewed not as luxuries but necessities. Whether analyzing gait to forestall strokes, nudging hypertensive patients about medication, or guiding dementia patients through calming routines, every new tool slots naturally into the Japan smart home healthcare market's overarching mission: keeping elders safer at home for longer. Corporate Titans Collaborate With Start-Ups To Build Robust Smart Healthcare Ecosystem Alliance Tech giants Fujitsu and Hitachi are actively developing smart healthcare technologies for remote diagnostics and telemedicine. The Sompo Group operates Sompo Care, which is the largest chain of nursing care facilities in Japan. The innovation arm of the Sompo Group, SOMPO Digital Lab, is focused on pioneering new initiatives in healthcare and eldercare. Medley Inc. is a key player in the telemedicine space with its popular 'Clinics Telemedicine System'. Aiphone, a public company founded in 1948, is a major manufacturer of video intercom systems for various sectors, including healthcare. Panasonic Corporation is a dominant force in the Japanese smart home market. Several international companies, including Schneider Electric SE, Emerson Electric Co., ABB Ltd., Honeywell International Inc., and Siemens AG, are also top players in Japan's smart home market. Other major Japanese corporations involved in the sector include Sony Group Corp., Mitsubishi Electric Corp., and Toshiba Corp. NEC Corporation is actively collaborating with government health agencies to develop AI-powered healthcare solutions. AI Robotics IoT And 5G Converge Delivering Seamless Preventive Assisted Living Experiences Technology is evolving so quickly that yesterday's prototypes feel commonplace today in the smart home healthcare market of Japan. Inside senior facilities, AI software now auto-compiles daily condition reports, thereby freeing human caregivers for empathetic interaction. Moreover, motion-sensing systems paired with AI have begun replacing disruptive nighttime bed checks. Outside institutional walls, telemedicine expanded significantly in 2025; this leap is underpinned by wearables that stream vitals for early alerts and humanoid robots such as Pepper that provide companionship and reminders. Connectivity poses no bottleneck because Japan already boasted nearly 70 million 5G subscriptions in 2023, enabling high-definition video consultations and on-device inference. Algorithmic accuracy keeps climbing—the latest medical-imaging AI reached 95 percent in 2024—while Tencent's oncology engine parsed ten million patient records that same year. Global forecasts predict telemedicine will dominate home care by 2030, and IoT devices will monitor 515 million patients worldwide in 2025. Even mobility assistance is evolving: February 2025 will see Transreport and Hankyu Corporation launch the Passenger Assistance Web platform to streamline travel for those with disabilities. Each of these building blocks slots seamlessly into the Japan smart home healthcare market, creating an ecosystem where context-aware care feels almost invisible yet profoundly supportive. Demographic Trends and Digital Mindsets Fuel Widespread Consumer Adoption Of Connected Wellness Ultimately, consumer behaviour validates market momentum. Adoption varies by device class: toileting-support hardware lingers at just 0.5 percent penetration, yet monitoring and communication devices now serve roughly 30 percent of caregiving settings. Tele-mental-health consultations are also gaining traction as stigma fades and convenience rises. Macro-demographics, however, guarantee that demand will swell: eight million baby boomers will cross the 75-year threshold in 2025, and by 2040 elderly-headed households will reach 6.87 million (65-plus) and 3.635 million (75-plus). Coupled with Japan's deep cultural enthusiasm for gadgets, the leap from smart speakers to smart sphygmomanometers appears entirely natural. Crucially, caregivers, clinicians, and municipal governments are coalescing around shared data frameworks, giving families confidence that devices will interoperate rather than trap them in siloed apps. As insurance reimbursements expand and local authorities subsidise installations, friction keeps shrinking—propelling the Japan smart home healthcare market from early-adopter novelty toward mainstream necessity. Collaborative Future Foresees Tech-Enabled Care Redefining Aging Paradigms Across Japanese Society Landscape As per Astute Analytica, Japan smart home healthcare market is no speculative bubble but a structurally supported growth arena. Over US $400 million single-party investments, ¥1.2 trillion in government funds, and a US $7.61 billion domestic smart-home revenue base underscore ample runway. Start-ups—42 and counting—supply nimble experimentation; conglomerates deliver manufacturing muscle; and policy provides the connective tissue from prototype to reimbursement. Most importantly, every sensor sold, robot deployed, or algorithm tuned addresses the nation's heaviest clinical burdens—from stroke and dementia DALYs to ever-present hypertension. By weaving medical intelligence into ordinary surroundings, Japan is building not merely smarter houses but a resilient social-care fabric capable of supporting the world's oldest population with dignity. Other nations will undoubtedly watch closely, because solutions perfected on tatami mats today may very well become blueprints for ageing societies everywhere tomorrow. Need a Customized Version? Request It Now: Japan Smart Home Healthcare Market Major Players: Apple Inc. F. Hoffmann-La Roche Ltd General Electric Company Samsung Electronics Co. Ltd. Medtronic Abbott Laboratories AT&T Inc. Siemens AG Fitbit Inc. Koninklijke Philips N.V. BSH Home Appliances Group Qualcomm Technologies, Inc. Schneider Electric SE Resideo Technologies, Inc. Other Prominent Players Key Segmentation: By Technology Wired Wireless By Products Testing, Screening and Monitoring Products Therapeutic Products Mobile Care Products By Service Skilled Nursing Services Rehabilitation Therapy Services Hospice and Palliative Care Services Unskilled Care Services Respiratory Therapy Services Infusion Therapy Services Pregnancy Care Services By Application Fall Prevention and Detection Health Status Monitoring Nutrition or Diet Monitoring Memory Aids By Indication Diabetes Respiratory Diseases Pregnancy Mobility Disorders Hearing Disorders Cancer Wound Care Request an Expert Consultation to Discuss the Report: About Astute Analytica Astute Analytica is a global market research and advisory firm providing data-driven insights across industries such as technology, healthcare, chemicals, semiconductors, FMCG, and more. We publish multiple reports daily, equipping businesses with the intelligence they need to navigate market trends, emerging opportunities, competitive landscapes, and technological advancements. With a team of experienced business analysts, economists, and industry experts, we deliver accurate, in-depth, and actionable research tailored to meet the strategic needs of our clients. At Astute Analytica, our clients come first, and we are committed to delivering cost-effective, high-value research solutions that drive success in an evolving marketplace. Contact Us:Astute AnalyticaPhone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World)For Sales Enquiries: sales@ Follow us on: LinkedIn | Twitter | YouTube CONTACT: Contact Us: Astute Analytica Phone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World) For Sales Enquiries: sales@ Website:
Yahoo
16-06-2025
- Health
- Yahoo
This common molecule could reverse muscle ageing and prevent frailty, scientists say
A common molecule found in the body could be targeted to turn aged muscle cells to become young again, helping prevent frailty in older people, a new study suggests. The populations of developed countries are getting older, leading to higher rates of associated frailty and debilitation among their people. Gradual muscle loss in these populations is accelerated by the poor capacity of muscle tissues in older people to repair injury, especially after falls or surgeries. This leads to a condition called sarcopenia, or low muscle mass, in older people, making them prone to even more frailty and movement problems. Previous studies have shown that muscle stem cells play a key role in repairing such tissue damage, but they become dysfunctional with age. Researchers have been trying to understand how aged stem cells differ from young ones and to find ways to reverse these changes. A new study, published in the journal Cell Stem Cell, reveals that aged mice treated with a naturally occurring molecule in the body called Prostaglandin E2 (PGE2) show improved regeneration and strength of aged muscle. Scientists also found that the PGE2 molecule works by counteracting stem cell ageing. In the study, researchers examined the effects of PGE2 and its related molecule EP4 on the body. Previous research has shown that during muscle injury, PGE2 triggers muscle stem cells to regenerate the muscles of young mice. In aged mice, scientists found that the EP4 production in muscle stem cells was either lacking, or reduced by half compared to levels found in young stem cells. 'PGE2 is an alarm clock to wake up the stem cells and repair the damage. Aging essentially reduces the volume of the alarm and the stem cells have also put on ear plugs,' said study author Yu Xin Wang. The new research has found a way to reset the intensity of this cellular alarm clock. When scientists gave a stable form of PGE2 to aged mice after muscle injury and in conjunction with exercise, they found that the treated mice gained more muscle mass and were stronger compared to untreated ones. 'What amazes me most is that a single dose of treatment is sufficient to restore muscle stem cell function, and that the benefit lasts far beyond the duration of the drug,' Dr Wang said. 'In addition to making new muscle, the stem cells stay in the tissue, where they sustain the effect of the PGE2 and instil the muscle with further capacity to regenerate,' he said. The study found that PGE2 treatment can restore stem cell function and reverse many of the age-related changes in mice muscles. 'PGE2 has been implicated in the regenerative process and signalling for the intestine, liver, and several other tissues, potentially opening up an approach that could restore the renewing capacity of other aged tissues,' Dr Wang said. 'We have discovered that the PGE2 induces rejuvenation of aged muscle stem cells, which leads to functional improvements in muscle repair and strength,' scientists concluded.
The Independent
16-06-2025
- Health
- The Independent
This common molecule could reverse muscle ageing and prevent frailty, scientists say
A common molecule found in the body could be targeted to turn aged muscle cells to become young again, helping prevent frailty in older people, a new study suggests. The populations of developed countries are getting older, leading to higher rates of associated frailty and debilitation among their people. Gradual muscle loss in these populations is accelerated by the poor capacity of muscle tissues in older people to repair injury, especially after falls or surgeries. This leads to a condition called sarcopenia, or low muscle mass, in older people, making them prone to even more frailty and movement problems. Previous studies have shown that muscle stem cells play a key role in repairing such tissue damage, but they become dysfunctional with age. Researchers have been trying to understand how aged stem cells differ from young ones and to find ways to reverse these changes. A new study, published in the journal Cell Stem Cell, reveals that aged mice treated with a naturally occurring molecule in the body called Prostaglandin E2 (PGE2) show improved regeneration and strength of aged muscle. Scientists also found that the PGE2 molecule works by counteracting stem cell ageing. In the study, researchers examined the effects of PGE2 and its related molecule EP4 on the body. Previous research has shown that during muscle injury, PGE2 triggers muscle stem cells to regenerate the muscles of young mice. In aged mice, scientists found that the EP4 production in muscle stem cells was either lacking, or reduced by half compared to levels found in young stem cells. 'PGE2 is an alarm clock to wake up the stem cells and repair the damage. Aging essentially reduces the volume of the alarm and the stem cells have also put on ear plugs,' said study author Yu Xin Wang. The new research has found a way to reset the intensity of this cellular alarm clock. When scientists gave a stable form of PGE2 to aged mice after muscle injury and in conjunction with exercise, they found that the treated mice gained more muscle mass and were stronger compared to untreated ones. 'What amazes me most is that a single dose of treatment is sufficient to restore muscle stem cell function, and that the benefit lasts far beyond the duration of the drug,' Dr Wang said. 'In addition to making new muscle, the stem cells stay in the tissue, where they sustain the effect of the PGE2 and instil the muscle with further capacity to regenerate,' he said. The study found that PGE2 treatment can restore stem cell function and reverse many of the age-related changes in mice muscles. 'PGE2 has been implicated in the regenerative process and signalling for the intestine, liver, and several other tissues, potentially opening up an approach that could restore the renewing capacity of other aged tissues,' Dr Wang said. 'We have discovered that the PGE2 induces rejuvenation of aged muscle stem cells, which leads to functional improvements in muscle repair and strength,' scientists concluded.
